🇺🇸 FDA
Pipeline program

GDC-0084

19-359

Phase 1 small_molecule active

Quick answer

GDC-0084 for Brain Metastases is a Phase 1 program (small_molecule) at KAZIA THERAPEUTICS LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
KAZIA THERAPEUTICS LTD
Indication
Brain Metastases
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials